BRAF and neoplasm: Notably, the authors also observed that BRAF exon 15 p.V600E mutant CRC patients featuring microsatellite-stable (MSS) tumor patterns had significantly lower OS rates than MSI tumors, regardless of the stage of the disease (II to IV) [98].